Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_419a2f26739946e4eaf067d3efbcb2ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a2e81107d5f4d52fd2d91d851a8f4f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71df20ca02909a9dd88180764e927689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_299a23c7cf0c165c89d8a5531001d561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89eb65e42a4d709543375cf89cc57a44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11a4f6716af957cc7ebd4dbc80634bd8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-44 |
filingDate |
2011-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ce8ba34caf2109acff42270a7143809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b696fcb8d67a83f779477f2d9ae1c102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad8e5cfc0558d01797fb18e01049967d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_873c5e8db7b0415a37c91fea470092f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53d5e377256d0e360242a062a49ac207 |
publicationDate |
2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2012009613-A1 |
titleOfInvention |
Pharmaceutical composition for modulating the activity of a novel triglyceride hydrolase |
abstract |
Use of an inhibitor or activator of the triglyceride hydrolyse activity of a protein comprising a polypeptide strand encoded by the DNA sequence according to SEQ No. 1 for the preparation of a pharmaceutical composition for the treatment of medical disorders where it is desirable to modulate the activity of a protein encoded by the DNA sequence according to SEQ No. 1. |
priorityDate |
2004-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |